Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy

https://doi.org/10.1016/0002-9149(91)90090-8Get rights and content

Abstract

Coronary angioplasty without prior thrombolytic therapy was performed in 383 patients with acute myocardial infarction (AMI). Patients were divided into 2 groups depending on whether they were candidates or non-candidates for thrombolytic therapy. Patients were not considered thrombolytic candidates if they: (1) presented in cardiogenic shock, (2) were ≥ 75 years of age, (3) had had coronary artery bypass surgery or, (4) had a reperfusion time of > 6 hours. Thrombolytic and nonthrombolytic candidates had similar rates of reperfusion (92 vs 88%), nonfatal reinfarction (6.0 vs 5.9%) and recurrent myocardial ischemia (1.8 vs 0%). Thrombolytic candidates had a lower mortality rate (3.9 vs 24%, p < 0.0001) and a lower incidence of bleeding (4.6 vs 10.9%, p < 0.05). Improvement in left ventricular ejection fraction at follow-up angiography was 4.4% in thrombolytic and 10.5% in nonthrombolytic candidates (p < 0.002). Ejection fraction improved most in patients with anterior wall AMI (7.7% in thrombolytic candidates, 15.1% in nonthrombolytic candidates) and in patients with reperfusion times > 6 hours (14.2%).

These outcomes suggest that direct coronary angioplasty is a viable alternative method of reperfusion in patients with AMI who are candidates for thrombolytic therapy. Nonthrombolytic candidates are a high-risk group of patients. Direct coronary angioplasty may be beneficial in certain subgroups, especially for patients in cardiogenic shock and for patients presenting > 6 hours after the onset of chest pain with evidence of ongoing ischemia.

References (27)

  • CL Grines et al.

    Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications

    Am J Cardiol

    (1990)
  • JK Kahn et al.

    Usefulness of angioplasty during acute myocardial infarction in patients with prior coronary artery bypass grafting

    Am J Cardiol

    (1990)
  • A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days

    N Engl J Med

    (1986)
  • Cited by (107)

    • Acute ST-segment elevation myocardial infarction: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)

      2008, Chest
      Citation Excerpt :

      Although most evaluations of PCI have been in patients who are eligible to receive fibrinolysis, there may be substantial value of PCI in patients who may not be suitable for fibrinolytic therapy because of an increased risk of bleeding.23 While there are no randomized controlled trials evaluating the outcome of PCI for patients who present with STE MI but who are ineligible for fibrinolytic therapy, these patients are at increased risk for mortality,24 and it has been suggested that PCI be considered for achieving reperfusion in these patients.23–26 1.0.1.

    • Gender-Age Interaction in Early Mortality Following Primary Angioplasty for Acute Myocardial Infarction<sup>†</sup>

      2006, American Journal of Cardiology
      Citation Excerpt :

      Subsequently, randomized trials have demonstrated that primary angioplasty is superior to thrombolytic therapy in decreasing cardiovascular morbidity and mortality.7 Moreover, primary angioplasty appears to be particularly beneficial in higher risk patient subsets.8,9 Consistent with this possibility, several studies have noted a decrease in mortality rates for women compared with men after primary angioplasty for AMI.10,11

    • Guidelines for percutaneous coronary interventions

      2005, Revista Espanola de Cardiologia
    • Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention

      2004, Chest
      Citation Excerpt :

      Studies16,17 have emphasized that primary PCI appears to be superior to thrombolytic therapy in terms of immediate restoration of normal coronary flow in the IRA and reduction of recurrent ischemia or reinfarction. Furthermore, primary PCI has been considered to be particularly beneficial in higher-risk patient subsets.17,22,23 However, there are few reports regarding the impact of primary PCI on early outcomes in women vs men.

    • Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction

      2003, American Heart Journal
      Citation Excerpt :

      Our results indicate a reduction in the incidence of reinfarction and in the need for repeat revascularization because of recurrent ischemia, with a significantly lower incidence of major bleeding complications in patients treated with primary angioplasty with routine stenting, compared with thrombolytic therapy, in elderly patients. Previous studies have yielded limited and conflicting data on the advantage of primary angioplasty compared with thrombolytic therapy in elderly patients with AMI.12,13,21–30 Earlier trials have suggested that high-risk patients with evolving infarction, associated with a high mortality rate, such as advanced age (>70 years), anterior infarction, persistent tachycardia, or cardiogenic shock, are most likely to benefit from immediate angioplasty.21,22

    • Interventional procedures in acute myocardial infarction

      2001, American Heart Journal
      Citation Excerpt :

      O’Keefe et al8 reported that 96% of 1000 consecutive patients with acute MI were acceptable candidates for percutaneous intervention, whereas nearly two thirds of the group had at least relative contraindications to thrombolytic therapy. In addition, because of actual or perceived contraindications, it has been documented that many patients with acute ST elevation MI are not treated with thrombolytic therapy and that these “lytic-ineligible” patients have a higher mortality rate.9-11 Primary PCI can be performed in nearly all these patients with a success rate greater than 90%.

    View all citing articles on Scopus

    This work was supported by a grant from the Education Committee, The Moses H. Cone Memorial Hospital, Greensboro, North Carolina, and by a grant from United States Catheters and Instruments division of CR Bard, Inc., Billerica, Massachusetts.

    View full text